OA02.02 Correlates of high HIV transmission areas in a generalized hyperendemic setting: findings from a national survey in EswatiniOral Abstract SessionTreatment as prevention
OA02.03 Progress toward HIV elimination goals: trends in and projections of treatment as prevention strategy in 38 African countriesOral Abstract SessionTreatment as prevention
PE29.01 CCR5 antibody blockade protects rhesus macaques from rectal SHIV acquisitionE-posterTreatment as prevention
PU29.01 Programming for female sex workers during COVID-19 pandemic: experiences from Bar Hostess Empowerment and Support Program, Nairobi KenyaPublication OnlyTreatment as prevention
OA02.05LB Risk factors for HIV transmission in heterosexual men, men who have sex with men, and transgender women participating in the HVTN 702 'Uhambo' and HVTN 503/503-S 'Phambili' HIV vaccine trialsOral Abstract SessionTransmission of HIV
OA22.01 R5 tropic HIV-1 is preferentially translocated of across genital mucosa while X4 tropic HIV-1 is selectively sequestered in genital epithelial cells and activates type I IFN signalingOral Abstract SessionTransmission of HIV
PE28.01 An analysis of gender-based violence and HIV risk among adolescents and youth across 10 countriesE-posterTransmission of HIV
PE28.02 Variable HIV seroincidence rates in a cohort of high-risk men who have sex with men (MSM) and transgender women (TGW) in ChinaE-posterTransmission of HIV
PE28.03 Site-level prevalence of gonorrhea and chlamydia is correlated with site-level HIV incidence in African women seeking contraceptionE-posterTransmission of HIV
PE28.04 Circulating South African transmitted/founder HIV-1 subtype C uses CCR5 and not CXCR4 or CCR3 for cell entryE-posterTransmission of HIV
seek-warrow-warrow-eseek-e1 - 10 of 444 items